# Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial

> **NCT01465828** · PHASE3 · COMPLETED · sponsor: **Gennaro Sardella** · enrollment: 30 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Clopidogrel
- **DRUG:** prasugrel

## Key facts

- **NCT ID:** NCT01465828
- **Lead sponsor:** Gennaro Sardella
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01465828

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01465828, "Therapy With High Clopidogrel Dose or Prasugrel Standard Dose Reduces the Platelet Reactivity in Patients With Genotype Variation RESET GENE Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01465828. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*